Clarithromycin ER tablets bulk supplier for pharma manufacturers

Clarithromycin Er Tablets 500 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Tablets

Available Strengths: 500 mg

Reference Brands: Biaxin (EU & US)

Clarithromycin ER tablets inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking translocation. They effectively treat respiratory, skin, and Helicobacter pylori infections. Benefits include rapid, broad-spectrum activity, improved tissue penetration, and convenient once-daily dosing for long-term infection management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Clarithromycin ER (Extended-Release) tablets are approved in the EU and US for respiratory, skin, and Helicobacter pylori infections. In the EU, brands like Biaxin XL are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generics available. Both regions require detailed dossiers, clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for clarithromycin ER tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.

Clarithromycin Er Tablets — third party manufacturing & bulk supply

Clarithromycin Er Tablets 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clarithromycin Er Tablets is supplied as Extended-Release Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clarithromycin Er Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clarithromycin Er Tablets →

Back to Listing

Frequently Asked Questions

Clarithromycin ER tablets is listed as Extended-Release Tablets in 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Clarithromycin ER tablets is referenced against Biaxin (EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.